Amlodipine Completed Phase 2 Trials for Insulin Resistance / Metabolic Syndromes / High Blood Pressure (Hypertension) / Endothelial Dysfunction Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00417170Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome